Literature DB >> 9029069

Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques.

S D Ginsberg1, P B Crino, V M Lee, J H Eberwine, J Q Trojanowski.   

Abstract

The polypeptide composition of neurofibrillary tangles (NFTs) and senile plaques (SPs) has been characterized extensively within the Alzheimer's disease (AD) brain. Because few data exist on the nonproteinaceous components of these lesions, we sought to determine if NFTs, neuropil threads (NTs), and SPs contain RNA species. To accomplish this, acridine orange (AO) histofluorescence was employed, alone or in combination with thioflavine S (TS) staining and immunohistochemistry to identify RNAs in paraffin-embedded tissue sections of hippocampus and entorhinal cortex. Postmortem brain samples came from 32 subjects including AD and elderly Down's syndrome (DS) patients, age-matched normal controls, and non-AD diseased controls. AO stained the cytoplasm of normal hippocampal and entorhinal neurons in all of the cases, while NFTs, NTs, and SPs were AO-positive in the same regions of AD and DS brains. Cytoplasmic AO histofluorescence was abolished with RNase, but not DNase or proteinase K, indicating the relative specificity of AO for RNA species. Quantitative analysis of double-labeled sections demonstrated that approximately 80% of TS-positive NFTs also were AO-positive, whereas approximately 55% of TS-stained SPs contained AO labeling. These novel observations demonstrate the presence of RNAs in NFTs, NTs, and SPs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9029069     DOI: 10.1002/ana.410410211

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  52 in total

Review 1.  Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

Authors:  M Goedert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  Paired helical filaments of inclusion-body myositis muscle contain RNA and survival motor neuron protein.

Authors:  A Broccolini; W K Engel; R B Alvarez; V Askanas
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

3.  Understanding the kinetic roles of the inducer heparin and of rod-like protofibrils during amyloid fibril formation by Tau protein.

Authors:  Gayathri Ramachandran; Jayant B Udgaonkar
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

4.  Neuron-specific age-related decreases in dopamine receptor subtype mRNAs.

Authors:  Scott E Hemby; John Q Trojanowski; Stephen D Ginsberg
Journal:  J Comp Neurol       Date:  2003-02-03       Impact factor: 3.215

Review 5.  Expression profile analysis of neurodegenerative disease: advances in specificity and resolution.

Authors:  Jason G Glanzer; Phillip G Haydon; James H Eberwine
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

6.  Antiviral agents in Alzheimer's disease: hope for the future?

Authors:  Matthew A Wozniak; Ruth F Itzhaki
Journal:  Ther Adv Neurol Disord       Date:  2010-05       Impact factor: 6.570

Review 7.  Single cell gene expression profiling in Alzheimer's disease.

Authors:  Stephen D Ginsberg; Shaoli Che; Scott E Counts; Elliott J Mufson
Journal:  NeuroRx       Date:  2006-07

8.  Selective incorporation of polyanionic molecules into hamster prions.

Authors:  James C Geoghegan; Pablo A Valdes; Nicholas R Orem; Nathan R Deleault; R Anthony Williamson; Brent T Harris; Surachai Supattapone
Journal:  J Biol Chem       Date:  2007-10-16       Impact factor: 5.157

9.  Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease.

Authors:  Chelsea T Tiernan; Stephen D Ginsberg; Bin He; Sarah M Ward; Angela L Guillozet-Bongaarts; Nicholas M Kanaan; Elliott J Mufson; Scott E Counts
Journal:  Neurobiol Dis       Date:  2018-05-31       Impact factor: 5.996

10.  Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau.

Authors:  Kentaro Tanemura; Miyuki Murayama; Takumi Akagi; Tsutomu Hashikawa; Takashi Tominaga; Michinori Ichikawa; Haruyasu Yamaguchi; Akihiko Takashima
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.